Non-medical cannabis use: international policies and outcomes overview. An outline for Portugal
Trends psychiatry psychother. (Impr.)
;
44(supl.1): e20200239, 2022. tab
Artículo
en Inglés
|
LILACS-Express
| LILACS
| ID: biblio-1377457
ABSTRACT
Abstract Introduction Cannabis is probably the most commonly used illicit drug. It is often regarded as a relatively nonharmful experience, even though evidence indicates otherwise. Legalization of non-medical cannabis, which has already taken place in several countries, is currently a controversial issue. Objective To provide an up-to-date overview of current models and policies and their outcomes that can inform future political decisions regarding non-medical cannabis use. Methods PubMed/MEDLINE and Google Scholar scientific databases were searched for articles written in English, Spanish, and Portuguese published between 1990 and December 2020. The reference lists of these articles were similarly used as bibliography sources. Gray literature was also included. Results While non-medical cannabis has been decriminalized in many countries, it has only been legalized in Uruguay, Canada, and some U.S. states. Several benefits of legalization were identified decreases in cannabis-related crimes, law-enforcement and judicial costs; reduction in synthetic cannabis supply; decline in black economies and possible diminution of other illegal drug buying; and tax revenue increases. Reported legalization problems included increases in cannabis use; cannabis-related disorders; and cannabis-related accidents and hospitalizations. Harm-reduction strategies are available in the scientific literature. Conclusion Growing, although incomplete, evidence exists to guide policy makers, minimize cannabis-related harm, and positively contribute to public health, if the legalization path is to be followed. Dialogue between legislators and science should be encouraged. There are more than a few legalization pathways, with diverse economic, social and health wellbeing effects. Public health-driven, instead of profit-driven models, seem to offer the most benefits regarding non-medical cannabis legalization. Most of the true public health effects of cannabis legalization are still unknown, for we are still in the early stages of these policies and their implications. Future studies should address the medium-to-long-term social, economic, and health consequences of legalization policies.
Texto completo:
Disponible
Índice:
LILACS (Américas)
Tipo de estudio:
Estudio pronóstico
/
Revisiones Sistemáticas Evaluadas
Idioma:
Inglés
Revista:
Trends psychiatry psychother. (Impr.)
Asunto de la revista:
Psiquiatria
Año:
2022
Tipo del documento:
Artículo
País de afiliación:
Dinamarca
/
Portugal
Institución/País de afiliación:
Hospital Prof. Dr. Fernando Fonseca/PT
/
Regionspsykiatrien Vest/DK
/
Unidade Local de Saúde de Castelo Branco/PT
Similares
MEDLINE
...
LILACS
LIS